TABLE 5.

Outcomes for patients receiving monotherapy for Pseudomonas aeruginosa infection

OutcomeNo. (%) of patientsP value
Colistin group (n = 18)Control group (n = 35)
Nephrotoxicity4 (22)5 (14)0.47
Clinical response at:
    Day 611 (61)9 (26)0.012
    End of therapy11 (61)11 (31)0.038
Microbiologic response at:
    Day 611 (61)12 (34)0.062
    End of therapy11 (61)13 (37)0.097
Relapse02 (6)0.54
Infection-related mortality4 (22)9 (26)>0.99
Overall mortality12 (67)16 (46)0.15